Published April 25, 2017. Sources: Interviews with representatives of the biotech firms below and BIV research.
|Rank '17||Company||Top local executive(s)||Areas of research||Year founded||No. staff worldwide 2016||Total BC staff 2016||No R&D staff 2016|
|1|| Stemcell Technologies Inc
1618 Station St
|Allen Eaves (president and CEO)||Provides cell culture media, cell separation tools and accessory reagents for cell biology research, including stem cell biology, regenerative medicine, immunology and cancer research||1993||846||625||224|
|2|| Arbutus Biopharma Corp
8900 Glenlyon Pky Suite 100
|Mark Murray (president and CEO); Bruce Cousins (EVP and CFO)||Discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection (HBV) with a pipeline consisting of multiple drug candidates with complementary mechanisms of action (Currently: RNAi, Capsid Assembly Inhibitor, Lipid Nanoparticle (LNP) technology, Future: multiple small molecule programs)||1992||122||90|
|3|| Kardium Inc
8518 Glenlyon Pky Suite 155
|Doug Goertzen (CEO)||Cardiovascular||2007||104||95||80|
|4|| Xenon Pharmaceuticals Inc
3650 Gilmore Way Suite 200
|Simon Pimstone (president and CEO)||Pain, epilepsy, dermatology||1996||100||91||70|
|5|| Novadaq Technologies Inc
8329 Eastlake Dr Suite 101
|Arthur Bailey (VP, engineering and manufacturing)||Fluorescence imaging for devices used in a variety of both open-field and minimally invasive surgery||1999||100||60|
We are glad you are enjoying BIV.com
To get unlimited access to all of our online features, upgrade today.
Already a member? Login
Business in Vancouver makes every attempt to publish accurate information in the List, but accuracy cannot be guaranteed. Lists are researched by Carrie Schmidt and Anna Liczmanska. For questions or to provide feedback, please contact us by email, firstname.lastname@example.org.
No related articles